Ipsen
From Wikipedia, the free encyclopedia
| Ipsen | |
|---|---|
 |
|
| Type | |
| Founded | 1929 |
| Headquarters | Paris, France |
| Industry | Pharmaceutical |
| Products |
|
| Employees | nearly 4,000 |
| Website | www.ipsen.com |
Ipsen is a European pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. In 2005, Ipsen spent € 169 million—20.9% of consolidated sales—on research and development, according to the IFRS.
|
|||||
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
